A Study of ONTAK and CHOP in Newly Diagnosed, Peripheral T-Cell Lymphoma

Clinical trial NCT00211185 · COMPLETED

Trial details

NCT number: NCT00211185
Sponsor: Eisai Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Lymphoma, T-Cell, Peripheral

Start date: 2004-03-14
Primary completion: 2008-08-01
Enrollment: 49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.